ArticleClinical interventions in aging2026
Multimodal AI Model for Sarcopenia Detection: Integrating Chest CT and Clinical Parameters in Older Adults.
Article in Clinical interventions in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sarcopenia, an age-related syndrome marked by progressive loss of skeletal muscle mass and function, is associated with frailty, disability, falls, and increased mortality among older adults. However, existing diagnostic methods, such as dual-energy X-ray absorptiometry (DXA) and physical performance tests, are often inaccessible in routine clinical practice due to equipment and time constraints. Objective: This study aimed to develop and validated a multimodal, explainable AI model for identifying sarcopenia using routinely available chest CT scans and outpatient clinical data in older adults. Methods: A total of 290 participants (mean age 67.6 ± 5.8 years; 38.9% female) were included. A weakly supervised segmentation framework combining the Segment Anything Model (SAM) and Contrastive Language-Image Pretraining (CLIP) was employed to extract muscle features at the T12 level. Clinical variables, including anthropometric indices, lifestyle behaviors, and biochemical markers, were encoded and fused with imaging-derived features. A multi-layer perceptron (MLP) was trained to classify sarcopenia based on 2019 AWGS criteria. Model interpretability was assessed using SHAP (Shapley Additive Explanations) values. Results: The model achieved an AUC of 0.88 (95% CI: 0.83-0.92), accuracy of 0.85 (95% CI 0.82-0.89), sensitivity of 0.79 (95% CI: 0.70-0.987), and specificity of 0.88 (95% CI: 0.83-0.92). SHAP analysis revealed that gender, total triiodothyronine, creatine kinase, body mass index and creatinine were the most influential predictors. The fusion of weakly supervised learning and multimodal data enabled effective muscle region segmentation and improved diagnostic performance. Conclusion: In summary, we developed and internally validated an explainable multimodal AI model that integrates chest CT-derived muscle features with routine outpatient clinical variables for sarcopenia detection in older adults. The model demonstrated strong diagnostic performance and interpretability, highlighting its potential for opportunistic risk stratification in routine clinical workflows. Future multi-center validation and prospective studies are warranted to confirm its generalizability and long-term clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.